2016 International Congress

Wednesday, June 22, 2016

12:00pm-1:30pm

A new tool to stage Parkinson’s disease PDCS (Parkinson’s disease composite scale): A pilot study on behalf of the European Parkinson’s disease association (EPDA)

F. Stocchi, P. Martinez-Martin, F.G. Radicati (Rome, Italy)

Phenomenology and clinical assessment of movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

A novel causal mutation for spinocerebellar ataxia 19/22 (SCA19)

C.M. Testa, V. Norris, J. Hoder, V. Hagood, R. Lewandowski, G.N. Tseng (Richmond, VA, USA)

Ataxia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

A proposed Parkinson’s disease neuropsychological battery (PNB)

L.L. van Wanrooij, J. Hoogland, J.G. Goldman, G. Stebbins, G.J. Geurtsen, D. Weintraub (Amsterdam, Netherlands)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

A randomized double-blind placebo- and positive-controlled crossover study to evaluate the effects of single doses of SD-809 (deutetrabenazine) and tetrabenazine on the corrected QT interval

D. Stamler, E. Offman, M. Bradbury, L. De Boer (La Jolla, CA, USA)

Huntington's disease  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

A step forward to the future: UPDRS kinematic measures for telemedicine

G. Albani, C. Azzaro, F. Parisi, C. Ferraris, M. Giuberti, L. Contin, D. Pianu, L. Pradotto, V. Cimolin, N. Cau, M. Galli, R. Nerino, G. Ferrari, A. Mauro (Piancavallo, Italy)

Rating scales  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

A technological solution for monitoring Parkinson’s disease: A patient-based perspective on necessity, usability and acceptability

S. Couth, E. Poliakoff, J. Vega, C. Jay, S. Harper, R. Almutiry, T.F. Cootes, A.M. Ramsay, S.A. Kotz (Manchester, United Kingdom)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

A unique phenotype associated with anti-GAD antibodies

A.P. Mentreddi, S. Chitnis, P. Khemani (Dallas, TX, USA)

Ataxia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Abnormal findings in polisomnographic records of patients with spinocerebellar ataxia type 2 (SCA2)

A. Zanatta, A.C.d.S. Crippa, F.M.B. Germiniani, H.A.G. Teive (Curitiba, Brazil)

Ataxia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Abnormal intrinsic brain activity reveals neural correlates of impaired cognitive function in early stage of Huntington’s disease (HD): A resting-state fMRI study

W. Liu, J. Yang, K. Chen, C. Luo, J.M. Burgunder, Q. Gong, H. Shang (Chengdu, People's Republic of China)

Huntington's disease  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Accuracy of clinical diagnosis of dementia with Lewy bodies: A systematic review and meta-analysis

G. Rizzo, S. Arcuti, M. Copetti, M. Alessandria, R. Savica, A. Fontana, R. Liguori, G. Logroscino (Bologna, Italy)

Cognitive disorders  ·  Exhibit Hall located in Hall B, Level 2